BLK vs STRO
BlackRock Inc (BLK) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BLK and STRO stock pages for the full models.
Not investment advice.